Vocus, Inc. (VOCS) Tops Q1 EPS by 2c; Guides Q2, Raises FY12 Outlook
Tweet
Share
E-mailGet Alerts VOCS Hot Sheet
Price: $17.98 --0%
Financial Fact:
Basic and diluted: -0.29
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Basic and diluted: -0.29
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Vocus, Inc. (NASDAQ: VOCS) reported Q1 EPS of $0.02, $0.02 better than the analyst estimate of $0.00. Revenue for the quarter came in at $35.5 million versus the consensus estimate of $34.9 million.
Vocus, Inc. sees Q2 2012 EPS of $0.08-$0.09, versus the consensus of $0.09. Vocus, Inc. sees Q2 2012 revenue of $43.5-$43.8 million, versus the consensus of $42.67 million.
Vocus, Inc. sees FY2012 EPS of $0.38-$0.40, versus the consensus of $0.36. Vocus, Inc. sees FY2012 revenue of $171.3-$172.5 million, versus the consensus of $170.7 million.
For earnings history and earnings-related data on Vocus, Inc. (VOCS) click here.
Vocus, Inc. sees Q2 2012 EPS of $0.08-$0.09, versus the consensus of $0.09. Vocus, Inc. sees Q2 2012 revenue of $43.5-$43.8 million, versus the consensus of $42.67 million.
Vocus, Inc. sees FY2012 EPS of $0.38-$0.40, versus the consensus of $0.36. Vocus, Inc. sees FY2012 revenue of $171.3-$172.5 million, versus the consensus of $170.7 million.
For earnings history and earnings-related data on Vocus, Inc. (VOCS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
